Geode Capital Management
HRMY icon

Geode Capital Management’s Harmony Biosciences HRMY Stock Holding History

Geode Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$60.8M Buy
1,549,610
+106,961
+7% +$4.13M ﹤0.01% 1486
2026
Q2 		$52.5M Buy
1,442,649
+119,929
+9% +$3.78M ﹤0.01% 1598
2026
Q1 		$37.1M Buy
1,322,720
+52,134
+4% +$1.71M ﹤0.01% 1661
2025
Q4 		$47.6M Buy
1,270,586
+12,323
+1% +$405K ﹤0.01% 1512
2025
Q3 		$34.7M Buy
1,258,263
+203,915
+19% +$7.02M ﹤0.01% 1702
2025
Q2 		$33.3M Buy
1,054,348
+88,598
+9% +$2.85M ﹤0.01% 1659
2025
Q1 		$32.1M Buy
965,750
+62,816
+7% +$2.25M ﹤0.01% 1635
2024
Q4 		$31.1M Buy
902,934
+167,516
+23% +$5.76M ﹤0.01% 1715
2024
Q3 		$29.4M Sell
735,418
-13,285
-2% -$467K ﹤0.01% 1769
2024
Q2 		$22.6M Sell
748,703
-5,074
-0.7% -$153K ﹤0.01% 1866
2024
Q1 		$25.3M Buy
753,777
+14,872
+2% +$477K ﹤0.01% 1779
2023
Q4 		$23.9M Buy
738,905
+19,529
+3% +$545K ﹤0.01% 1805
2023
Q3 		$23.6M Buy
719,376
+58,070
+9% +$2.02M ﹤0.01% 1719
2023
Q2 		$23.3M Buy
661,306
+87,681
+15% +$3.03M ﹤0.01% 1753
2023
Q1 		$18.7M Buy
573,625
+23,384
+4% +$1.06M ﹤0.01% 1846
2022
Q4 		$30.3M Buy
550,241
+19,957
+4% +$1.1M ﹤0.01% 1486
2022
Q3 		$23.5M Buy
530,284
+61,465
+13% +$3M ﹤0.01% 1614
2022
Q2 		$22.9M Buy
468,819
+27,205
+6% +$1.22M ﹤0.01% 1671
2022
Q1 		$21.5M Buy
441,614
+16,786
+4% +$685K ﹤0.01% 1855
2021
Q4 		$18.1M Buy
424,828
+13,718
+3% +$547K ﹤0.01% 2018
2021
Q3 		$15.8M Buy
411,110
+186,168
+83% +$5.99M ﹤0.01% 2127
2021
Q2 		$6.35M Buy
224,942
+124,185
+123% +$3.73M ﹤0.01% 2762
2021
Q1 		$3.33M Buy
100,757
+9,357
+10% +$328K ﹤0.01% 2986
2020
Q4 		$3.3M Buy
91,400
+44,904
+97% +$1.81M ﹤0.01% 2823
2020
Q3 		$1.58M Buy
+46,496
New +$1.7M ﹤0.01% 3003

Other funds holding HRMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Geode Capital Management's HRMY Position: Q3 2026 in Review

Geode Capital Management increased its Harmony Biosciences (HRMY) stake by 7.4% in Q3 2026, buying an estimated $4.13M and bringing the position to 1,549,610 shares worth $60.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

Geode Capital Management first reported a position in HRMY in Q3 2020 and has held it in 25 quarters since. 279 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Geode Capital Management held 1,549,610 shares of Harmony Biosciences worth $60.8M as of Q3 2026.
  • Geode Capital Management bought 106,961 Harmony Biosciences shares in Q3 2026, an estimated $4.13M.
  • Harmony Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #1486 holding.
  • Geode Capital Management first reported a position in Harmony Biosciences in Q3 2020 and has held it in 25 quarters since.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.